Phenylpropanolamine hydrochloride, or PPA, is a medicine utilized as a decongestant in several over-the-counter and prescription cough and cold medicines. Phenylpropanolamine hydrochloride has also been used in a number of weight loss products. The FDA has removed PPA from all drug products and has requested that all drug manufacturers stop marketing products including PPA. Additionally, the FDA distributed a public health advisory regarding the risk of hemorrhagic stroke, or bleeding into the brain, connected with Phenylpropanolamine hydrochloride. A report by scientists at Yale University School of Medicine concluded a direct association between PPA and increased risk of hemorrhagic stroke, mainly in women. Men may also be at risk, though to a lesser degree.
Stroke Warning Signs:
Sudden Weakness or Numbness of the face, arm/leg on one side of the body.
Sudden dimness or loss of vision particularly in one eye.
Loss of Speech, or trouble talking or understanding speech.
Sudden, severe headaches with no known or apparent cause.
Unexplained dizziness, unsteadiness or falls.
FREE DEFECTIVE DRUG RECALL Case Evaluation
The Drug Recall Help Center is a FREE consumer service and part of the Legal Help Center Network. Each month, more than 100,000 consumers visit our Legal Help Centers seeking to find legal help to evaluate their cases.
| Disclaimer
| Privacy Policy
| SITEMAP
